• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Flotek Surpasses 2024 Annual Guidance with Strong Fourth Quarter and Full-Year Results

    3/10/25 4:01:00 PM ET
    $FTK
    Major Chemicals
    Industrials
    Get the next $FTK alert in real time by email

    HOUSTON, March 10, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced operational and financial results for the fourth quarter and full-year ended December 31, 2024.  Fourth quarter 2024 results were the strongest quarterly results of 2024 in terms of revenue, gross profit, net income and adjusted EBITDA (1).

    Flotek Industries, Inc. (PRNewsfoto/Flotek Industries, Inc.)

    Financial Summary (in thousands, except 'per share' amounts)



    Three Months Ended

    December 31,



    Twelve Months Ended

    December 31,



    2024



    2023



    2024



    2023

















    Total Revenues

    $            50,758



    $            42,188



    $          187,025



    $          188,058

    Gross Profit

    $            12,277



    $              9,430



    $            39,386



    $            24,263

    Net Income

    $              4,429



    $              2,104



    $            10,498



    $            24,713

    Diluted Income (Loss) Per Share

    $                0.14



    $                0.07



    $                0.34



    $               (0.10)

    Adjusted EBITDA (1)

    $              7,023



    $              3,952



    $            20,327



    $              1,488

    Full-Year and Fourth Quarter 2024 Highlights

    • Q4 2024 total revenue rose 20% vs. Q4 2023, led by a 21% jump in external customer revenue—the highest in 5 years.
    • Data analytics service revenue grew 124% vs. Q4 2023 and 44% vs. full year 2023.
    • Gross profit climbed 30% vs. Q4 2023 and 62% vs. full year 2023, with Q4 2024 gross margin rising to 24%.
    • Q4 2024 net income was $4.4 million and adjusted EBITDA(1) totaled $7.0 million, up 111% and 78%, respectively, vs Q4 2023.
    • 2024 net income hit $10.5 million or $0.34/share, vs. a loss of $(0.10)/share in 2023.
    • 2024 adjusted EBITDA(1) reached $20.3 million, up $18.8 million from 2023—the highest since 2017—exceeding guidance of $18.5 million by 10%.

    Management Commentary

    Chief Executive Officer Dr. Ryan Ezell commented, "2024 marks a significant step in the execution of our corporate strategy towards the convergence between innovative Data and Chemistry solutions that deliver outstanding value to our customers and external stakeholders. This year, we not only achieved the highest profitability metrics in nearly a decade but did so through superior operational efficiency and service quality execution. Additionally, our commitment to safety has shone through, with no lost-time incidents recorded in the past three years.

    We've expanded our technology portfolio with the introduction of three cutting-edge Data Analytics solutions: VeraCal, JP3 Raman, and XSPCT, systems specifically designed to address the unique challenges of the energy and infrastructure sector while driving high-margin growth into 2025 and beyond. In the fourth quarter, we observed a significant transformation in our Data Analytics revenue resulting in a 67% sequential increase in service revenue furthering the shift from products to services.

    Looking ahead, we expect that the integration of Data and Chemistry at Flotek will provide exciting new innovations in the energy and infrastructure market. These advancements are set to empower our customers' assets to maximize returns, reduce costs, automate processes, and leverage data in ways previously unimaginable. We believe that our relentless pursuit to leverage chemistry as the common value creation platform will position Flotek as a leader in differentiated technologies and foster our future growth."

    Fourth Quarter and Full-Year 2024 Financial Results

    • Revenue: Flotek reported total revenues of $50.8 million for fourth quarter 2024, an increase of $8.6 million, or 20%, compared to total revenues of $42.2 million for fourth quarter 2023. Full-year 2024 total revenues totaled $187.0 million, as compared to total revenues of $188.1 million during 2023. Fourth quarter and full year 2024 revenues include $8.6 million and $32.4 million, respectively, related to the minimum purchase requirements under the Company's long-term supply agreement with ProFrac Services, LLC.

    Segment Revenue Summary (in thousands)



    Three Months Ended

    December 31,



    Twelve Months Ended

    December 31,



    2024



    2023



    2024



    2023

















    Chemistry Technologies:















     External Revenues

    $             21,071



    $             17,996



    $             63,214



    $             59,016

    Related Party Revenues

    27,215



    22,769



    114,947



    120,903

    Total

    $             48,286



    $             40,765



    $           178,161



    $           179,919

















    Data Analytics:















    Product Revenues

    $                   826



    $                   688



    $               4,745



    $               5,277

    Service Revenues

    1,646



    735



    4,119



    2,862

    Total

    $               2,472



    $               1,423



    $               8,864



    $               8,139

    • Gross Profit: The Company generated gross profit of $12.3 million during fourth quarter 2024 compared to a gross profit of $9.4 million during fourth quarter 2023. The improvement in fourth quarter 2024 gross profit was primarily the result of successful initiatives throughout 2024 to drive cost reductions with respect to freight, logistics and materials combined with an 18% increase in chemistry revenue and a 74% increase in data analytics revenue, as compared to fourth quarter 2023.



      The Company generated gross profit of $39.4 million for full-year 2024 compared to gross profit of $24.3 million for full-year 2023.
    • Selling, General and Administrative ("SG&A") Expense: SG&A expense totaled $6.6 million for the fourth quarters of 2024 and 2023. SG&A expense totaled $24.7 million for full-year 2024 compared to $27.8 million for full-year 2023, an 11% reduction year-over-year. Excluding non-cash stock compensation expense, 2024 SG&A expense is 17% lower than 2023.
    • Net Income (Loss) and EPS: Flotek reported net income of $4.4 million, or $0.14 per diluted share, for the fourth quarter 2024. This compares to net income of $2.1 million, or $0.07 per diluted share, for the fourth quarter 2023. Net income for full-year 2024 was $10.5 million, or $0.34 per diluted share, compared to net income (loss) of $24.7 million, or ($0.10) per diluted share, for the comparable period of 2023. Net income for full-year 2023 included non-cash gains related to the fair value measurement of convertible notes payable and a PPP loan forgiveness totaling $34.5 million.
    • Adjusted EBITDA (Non-GAAP)(1): Adjusted EBITDA(1) was $7.0 million in fourth quarter 2024 as compared to $4.0 million in fourth quarter 2023. Adjusted EBITDA(1) was $20.3 million for full-year 2024 compared to $1.5 million for full-year 2023.

    (1)

    See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information, including reconciliations to the most comparable GAAP measures.

    2025 Guidance

    Consistent with 2024 and 2023, Flotek plans to issue 2025 guidance in conjunction with the release of its first quarter 2025 financial and operating results.

    Upcoming Investor Event

    Flotek will participate in the 37th Annual Roth Conference to be held at the Marriott in Laguna Dana Point, California, March 17-18, 2025. Flotek Chief Executive Officer, Ryan Ezell, will participate in an industry panel discussion on March 17 at 10:00 a.m. PT and will be joined by Chief Financial Officer, Bond Clement, in hosting one-on-one meetings during the event. An updated corporate presentation to be used in discussions at the conference will be posted to the Investor Relations section of Flotek's corporate website at www.flotekind.com prior to the start of the conference.

    Conference Call Details

    Flotek will host a conference call on March 11, 2025, at 9:00 a.m. CT (10:00 a.m. ET) to discuss its fourth quarter and full-year 2024 results. Participants may access the call through Flotek's website at www.flotekind.com under "News" within the Investor Relations section, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the audience view of the webcast at https://app.webinar.net/qDjWg9qga1Y approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

    An updated corporate presentation that will be referenced on the call will be posted to the Investor Relations section of Flotek's website at www.flotekind.com prior to the start of the earnings conference call.

    About Flotek Industries, Inc.

    Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's top tier technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, 20+ years of field and laboratory data, and a global presence in more than 59 countries.

    Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.

    Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com. 

    Forward-Looking Statements

    Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.

    FLOTEK INDUSTRIES, INC.

     UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (in thousands, except share data)





    December 31, 2024



    December 31, 2023

    ASSETS







    Current assets:







    Cash and cash equivalents

    $                          4,404



    $                          5,851

    Restricted cash

    102



    102

    Accounts receivable, net of allowance for credit losses of $447 and $745 at

    December 31, 2024 and December 31, 2023, respectively

    17,386



    13,687

    Accounts receivable, related party, net of allowance for credit losses of $0 at

    each of December 31, 2024 and December 31, 2023, respectively

    52,370



    34,569

    Inventories, net

    13,303



    12,838

    Other current assets

    2,952



    3,564

    Current contract asset

    5,939



    5,836

    Total current assets

    96,456



    76,447

    Long-term contract asset

    63,105



    68,820

    Property and equipment, net

    6,178



    5,129

    Operating lease right-of-use assets

    3,326



    5,030

    Deferred tax assets, net

    51



    300

    Other long-term assets

    1,680



    1,787

    TOTAL ASSETS

    $                      170,796



    $                      157,513









    LIABILITIES AND STOCKHOLDERS' EQUITY







    Current liabilities:







    Accounts payable

    $                        38,073



    $                        31,705

    Accrued liabilities

    5,912



    5,890

    Income taxes payable

    48



    45

    Current portion of operating lease liabilities

    1,486



    2,449

    Current portion of finance lease liabilities

    —



    22

    Asset-based loan

    4,789



    7,492

    Current portion of long-term debt

    60



    179

    Total current liabilities

    50,368



    47,782

    Deferred revenue, long-term

    14



    35

    Long-term operating lease liabilities

    6,514



    7,676

    Long-term debt

    —



    60

    TOTAL LIABILITIES

    56,896



    55,553

    Commitments and contingencies







    Stockholders' equity:







    Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares

         issued and outstanding

    —



    —

    Common stock, $0.0001 par value, 240,000,000 shares authorized;

         30,938,073 shares issued and 29,826,508 shares outstanding at

         December 31, 2024; 30,772,837 shares issued and 29,664,130 shares

         outstanding at December 31, 2023

    3



    3

    Additional paid-in capital

    464,620



    463,140

    Accumulated other comprehensive income

    251



    127

    Accumulated deficit

    (316,308)



    (326,806)

    Treasury stock, at cost; 1,111,565 and 1,108,707 shares at December 31,

         2024 and December 31, 2023, respectively

    (34,666)



    (34,504)

    Total stockholders' equity

    113,900



    101,960

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

    $                      170,796



    $                      157,513

     

    FLOTEK INDUSTRIES, INC.

    Unaudited Condensed Consolidated Statements of Operations

    (in thousands, except per share data)





    Three Months Ended

    December 31,



    Twelve Months Ended

    December 31,



    2024



    2023



    2024



    2023

    Revenue:















    Revenue from external customers

    $              23,328



    $            19,239



    $            71,263



    $          66,518

    Revenue from related party

    27,430



    22,949



    115,762



    121,540

    Total revenues

    50,758



    42,188



    187,025



    188,058

    Cost of goods sold

    38,481



    32,758



    147,639



    163,795

    Gross profit

    12,277



    9,430



    39,386



    24,263

    Operating costs and expenses:















    Selling, general, and administrative

    6,630



    6,552



    24,709



    27,827

    Depreciation

    229



    204



    891



    734

    Research and development

    365



    255



    1,714



    2,486

    Gain on sale of property and equipment

    (90)



    —



    (124)



    (38)

    Gain in fair value of Contract Consideration

    Convertible Notes Payable

    —



    —



    —



    (29,969)

    Total operating costs and expenses

    7,134



    7,011



    27,190



    1,040

    Income from operations

    5,143



    2,419



    12,196



    23,223

    Other income (expense):















    Paycheck protection plan loan forgiveness

    —



    —



    —



    4,522

    Interest expense

    (253)



    (320)



    (1,095)



    (2,857)

    Other income (expense), net

    (105)



    56



    46



    (26)

    Total other (expense) income

    (358)



    (264)



    (1,049)



    1,639

    Income before income taxes

    4,785



    2,155



    11,147



    24,862

    Income tax expense

    (356)



    (51)



    (649)



    (149)

    Net income

    $                 4,429



    $               2,104



    $            10,498



    $          24,713

















    Income (loss) per common share:













    Basic

    $                   0.15



    $                 0.07



    $                0.36



    $               1.00

    Diluted

    $                   0.14



    $                 0.07



    $                0.34



    $             (0.10)

















    Weighted average common shares:















    Weighted average common shares used in

       computing basic income (loss) per common

       share

    29,642



    29,396



    29,534



    24,830

    Weighted average common shares used in

       computing diluted income (loss) per common

       share

    31,436



    30,496



    30,889



    28,377

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)





    Twelve Months Ended

    December 31,



    2024



    2023

    Cash flows from operating activities:







    Net income

    $                  10,498



    $                  24,713

    Adjustments to reconcile net income to net cash provided by (used in) operating activities:







    Change in fair value of contingent consideration

    71



    (527)

    Change in fair value of Contract Consideration Convertible Notes Payable

    —



    (29,969)

    Amortization of convertible note issuance costs

    —



    83

    Payment-in-kind interest expense

    —



    2,284

    Amortization of contract asset

    5,612



    5,033

    Depreciation

    891



    734

    Amortization of asset-based loan origination costs

    314



    121

    Provision for credit losses, net of recoveries

    181



    138

    Provision for excess and obsolete inventory

    645



    959

    Gain on sale of property and equipment

    (124)



    (38)

    Non-cash lease expense

    2,094



    3,014

    Stock compensation expense

    1,366



    (254)

    Deferred income tax expense

    249



    104

    Paycheck protection plan loan forgiveness

    —



    (4,522)

    Changes in current assets and liabilities:







    Accounts receivable

    (3,880)



    5,311

    Accounts receivable, related party

    (17,801)



    (11,886)

    Inventories

    (1,110)



    1,938

    Income taxes receivable

    8



    —

    Other assets

    561



    (836)

    Accounts payable

    6,368



    (1,670)

    Accrued liabilities

    (70)



    (2,575)

    Operating lease liabilities

    (2,515)



    (3,391)

    Income taxes payable

    3



    (53)

    Interest payable

    —



    (8)

    Net cash provided by (used in) operating activities

    3,361



    (11,297)

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)

    (continued)





    Twelve Months Ended

    December 31,



    2024



    2023

    Cash flows from investing activities:







    Capital expenditures

    (1,940)



    (1,081)

    Proceeds from sale of assets

    124



    67

    Net cash used in investing activities

    (1,816)



    (1,014)

    Cash flows from financing activities:







    Payment for forfeited stock options

    —



    (617)

    Payments on long term debt

    (179)



    (149)

    Proceeds from asset-based loan

    166,950



    68,716

    Payments on asset-based loan

    (169,653)



    (61,224)

    Payment of asset-based loan origination costs

    (164)



    (574)

    Payments to tax authorities for shares withheld from employees

    (162)



    (268)

    Proceeds from issuance of stock under Employee Stock Purchase Plan

    114



    77

    Payments for finance leases

    (22)



    (33)

    Net cash (used in) provided by financing activities

    (3,116)



    5,928

    Effect of changes in exchange rates on cash and cash equivalents

    124



    (54)

    Net change in cash and cash equivalents and restricted cash

    (1,447)



    (6,437)

    Cash and cash equivalents at the beginning of period

    5,851



    12,290

    Restricted cash at the beginning of period

    102



    100

    Cash and cash equivalents and restricted cash at beginning of period

    5,953



    12,390

    Cash and cash equivalents at end of period

    4,404



    5,851

    Restricted cash at the end of period

    102



    102

    Cash and cash equivalents and restricted cash at end of period

    $                    4,506



    $                    5,953

     

    FLOTEK INDUSTRIES, INC.

    Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

    (in thousands)





    Three Months Ended

    December 31,



    Twelve Months Ended

    December 31,



    2024



    2023



    2024



    2023

















    Gross profit

    $             12,277



    $               9,430



    $             39,386



    $             24,263

    Stock compensation expense

    15



    3



    24



    (132)

    Severance and retirement

    2



    3



    11



    29

    Contingent liability revaluation

    117



    (143)



    71



    (527)

    Amortization of contract asset

    1,271



    1,368



    5,612



    5,033

    Adjusted Gross profit (Non-GAAP) (1)

    $             13,682



    $             10,661



    $             45,104



    $             28,666

















    Net income

    $               4,429



    $               2,104



    $             10,498



    $             24,713

    Interest expense

    253



    320



    1,095



    2,857

    Income tax expense

    356



    51



    649



    149

    Depreciation and amortization

    229



    204



    891



    734

    EBITDA (Non-GAAP) (1)

    $               5,267



    $               2,679



    $             13,133



    $             28,453

    Stock compensation expense

    451



    307



    1,366



    (268)

    Severance and retirement

    7



    10



    39



    (17)

    Contingent liability revaluation

    117



    (143)



    71



    (527)

    Gain on disposal of assets

    (90)



    —



    (124)



    (38)

    PPP loan forgiveness

    —



    —



    —



    (4,522)

    Contract Consideration Convertible Notes Payable revaluation adjustment

    —



    —



    —



    (29,969)

    Amortization of contract asset

    1,271



    1,368



    5,612



    5,033

    Non-Recurring professional fees

    —



    (269)



    230



    3,343

    Adjusted EBITDA (Non-GAAP) (1)

    $               7,023



    $               3,952



    $             20,327



    $               1,488





    (1)

    Management believes that adjusted gross profit, EBITDA and adjusted EBITDA for the three and twelve months ended December 31, 2024 and 2023, are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods.  Management views the income and expenses noted above to be outside of the Company's normal operating results.  Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-surpasses-2024-annual-guidance-with-strong-fourth-quarter-and-full-year-results-302397404.html

    SOURCE Flotek Industries, Inc.

    Get the next $FTK alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $FTK

    DatePrice TargetRatingAnalyst
    6/17/2025$16.00Market Perform
    Northland Capital
    6/12/2025$19.00Buy
    Alliance Global Partners
    7/25/2024$6.50Buy
    ROTH MKM
    4/29/2024$7.00Buy
    Alliance Global Partners
    7/1/2021$2.50Outperform
    Noble Capital Markets
    More analyst ratings

    $FTK
    SEC Filings

    See more
    • SEC Form S-3 filed by Flotek Industries Inc.

      S-3 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

      7/10/25 4:14:51 PM ET
      $FTK
      Major Chemicals
      Industrials
    • SEC Form S-8 filed by Flotek Industries Inc.

      S-8 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

      7/10/25 4:08:47 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Industries Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure

      8-K - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

      7/9/25 4:07:40 PM ET
      $FTK
      Major Chemicals
      Industrials

    $FTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Wilks Matthew bought $190,535 worth of shares (13,442 units at $14.17) (SEC Form 4)

      4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/16/25 4:48:21 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Amendment: Director Wilks Matthew bought $1,650,912 worth of shares (136,324 units at $12.11) (SEC Form 4)

      4/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/15/25 4:16:07 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Director Wilks Matthew bought $1,650,912 worth of shares (136,324 units at $12.11) (SEC Form 4)

      4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/13/25 6:12:48 PM ET
      $FTK
      Major Chemicals
      Industrials

    $FTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $FTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $FTK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Director Agadi Harshavardhan V was granted 6,394 shares, increasing direct ownership by 2% to 264,221 units (SEC Form 4)

      4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/19/25 3:46:06 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Director Fucci Michael was granted 6,394 shares, increasing direct ownership by 8% to 83,144 units (SEC Form 4)

      4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/19/25 3:44:12 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Director Farber Evan R was granted 6,394 shares, increasing direct ownership by 12% to 60,895 units (SEC Form 4)

      4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

      5/19/25 3:39:22 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Northland Capital initiated coverage on Flotek Industries with a new price target

      Northland Capital initiated coverage of Flotek Industries with a rating of Market Perform and set a new price target of $16.00

      6/17/25 9:01:40 AM ET
      $FTK
      Major Chemicals
      Industrials
    • Alliance Global Partners initiated coverage on Flotek Industries with a new price target

      Alliance Global Partners initiated coverage of Flotek Industries with a rating of Buy and set a new price target of $19.00

      6/12/25 9:11:08 AM ET
      $FTK
      Major Chemicals
      Industrials
    • ROTH MKM initiated coverage on Flotek Industries with a new price target

      ROTH MKM initiated coverage of Flotek Industries with a rating of Buy and set a new price target of $6.50

      7/25/24 6:20:26 AM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Announces Second Quarter 2025 Earnings Release and Conference Call Schedule

      HOUSTON, June 23, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced the Company's schedule for releasing its second quarter 2025 financial and operating results. The Company plans to issue its second quarter 2025 financial and operating results press release after market close on Tuesday, August 5, 2025, and will host its earnings conference call on Wednesday, August 6, 2025, at 9:00 a.m. Central (10:00 a.m. Eastern). The press release will be posted on the Company's website at https://ir.flotekind.com/press-releases. Participa

      6/23/25 4:05:00 PM ET
      $FTK
      Major Chemicals
      Industrials
    • EnerCom Announces Liberty Energy and Baker Hughes as Keynote Speakers at the 30th Annual EnerCom Denver - The Energy Investment Conference

      Register for EnerCom Denver – The Energy Investment Conference, featuring a broad group of public and private energy companies at www.enercomdenver.com  Limited presentation opportunities remain for E&P, Midstream, OFS, Energy Transition, Nuclear and Emerging Technology companies Sponsorship opportunities are available for companies seeking to increase marketplace and brand awareness through EnerCom's multi-channel approach before, during, and after the event DENVER, June 19, 2025 /PRNewswire/ -- EnerCom, Inc. is pleased to announce that Ron Gusek, CEO of Liberty Energy and Amerino Gatti, Executive Vice President of Oilfield Services & Equipment for Baker Hughes have been confirmed as keynot

      6/19/25 11:23:00 AM ET
      $AMPY
      $APA
      $BKR
      $BKV
      Oil & Gas Production
      Energy
      Metal Fabrications
      Industrials
    • Flotek Industries Added to Russell 3000® Index

      HOUSTON, June 3, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) announced today that it will be added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30th, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in either the large-cap Russell 1000®

      6/3/25 8:30:00 AM ET
      $FTK
      Major Chemicals
      Industrials

    $FTK
    Leadership Updates

    Live Leadership Updates

    See more
    • Flotek Set to Join the Russell Microcap® Index

      HOUSTON, June 11, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) announced today that the company is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in th

      6/11/24 9:00:00 AM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Enhances Executive Leadership Team With Addition of Leon Chad as Senior Vice President, Commercial

      HOUSTON, June 10, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced that it has appointed Leon Chad as Senior Vice President, Commercial, effective June 3, 2024. This appointment serves as the replacement for the Company's Senior Vice President- Global Business Lines who departed in March 2024. With over three decades of both domestic and international experience in the energy and chemistry industries, Mr. Chad brings invaluable expertise that will further enhance the Company's strategy to drive market share gains through its d

      6/10/24 4:15:00 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Strengthens Executive Leadership Team with the Addition of Amy Blakeway as Senior Vice President, General Counsel

      HOUSTON, March 4, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced that it has appointed Amy Blakeway as Senior Vice President, General Counsel, effective March 1, 2024. With over a decade of legal experience in the energy sector, Ms. Blakeway brings unique expertise that will further strengthen the leadership team and help advance the Company's growth strategy to drive market share gains through its differentiated chemistry and data solutions. Ryan Ezell, Chief Executive Officer, said, "I am pleased to welcome Amy as the newe

      3/4/24 4:15:00 PM ET
      $FTK
      Major Chemicals
      Industrials

    $FTK
    Financials

    Live finance-specific insights

    See more
    • Flotek Announces Second Quarter 2025 Earnings Release and Conference Call Schedule

      HOUSTON, June 23, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced the Company's schedule for releasing its second quarter 2025 financial and operating results. The Company plans to issue its second quarter 2025 financial and operating results press release after market close on Tuesday, August 5, 2025, and will host its earnings conference call on Wednesday, August 6, 2025, at 9:00 a.m. Central (10:00 a.m. Eastern). The press release will be posted on the Company's website at https://ir.flotekind.com/press-releases. Participa

      6/23/25 4:05:00 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Provides Strong 2025 Outlook in Connection with Announcing Robust First Quarter 2025 Revenue and Profit Growth

      HOUSTON, May 6, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced operational and financial results for the quarter ended March 31, 2025.  First quarter 2025 results were the strongest quarterly results in terms of revenue, gross profit, net income and adjusted EBITDA (1) in the last 5 years. Financial Summary (in thousands, except 'per share' amounts) Three Months Ended March 31, 2025 2024 % Change Total Revenues $                    55,362 $                    40,374 37 % Gross Profit $                    12,449 $           

      5/6/25 4:05:00 PM ET
      $FTK
      Major Chemicals
      Industrials
    • Flotek Acquires Innovative Mobile Power Generation Assets and Secures Multi-Year Lease Providing $160 Million Revenue Backlog and Immediate Earnings Accretion

      HOUSTON, April 28, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek") (NYSE:FTK) and ProFrac Holding Corp. (NASDAQ:ACDC) ("ProFrac") today jointly announced Flotek's acquisition of power generation assets and related intellectual property (the "Acquired Assets") from ProFrac GDM, LLC ("ProFrac GDM"), a subsidiary of ProFrac, for $105 million. Flotek concurrently entered into an agreement for a six-year dry lease of the Acquired Assets with ProFrac GDM (the "Lease Agreement"). The Acquired Assets include digitally enhanced mobile natural gas conditioning and distribution u

      4/28/25 4:05:00 PM ET
      $ACDC
      $FTK
      Oilfield Services/Equipment
      Energy
      Major Chemicals
      Industrials

    $FTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

      SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

      6/9/23 1:03:35 PM ET
      $FTK
      Major Chemicals
      Industrials
    • SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

      SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

      12/28/22 4:15:37 PM ET
      $FTK
      Major Chemicals
      Industrials
    • SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

      SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

      8/29/22 4:13:00 PM ET
      $FTK
      Major Chemicals
      Industrials